Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
Medical Management
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Megestrol acetate
ACTUATE THERAPEUTICS, INC.
HIV Infections
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Intracerebral Hemorrhage
1 trial -
Misoprostol
Children's Hospital of Fudan University
Postpartum Hemorrhage
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Multi-component intervention package
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multistrain Probiotic
Ultragenyx UK Limited
Cystic Fibrosis in Children
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
Neo-ASA
Ultragenyx UK Limited
Argininosuccinate Lyase Deficiency
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Oliceridine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypoxemia During Surgery
1 trial -
Oligo Fucoidan
Biotech Pharmaceutical Co.,
NSCLC Stage IV
1 trial -
Omeprazole
Hospital Authority, Hong Kong
Gastroesophageal Reflux Disease
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oxygen
United Therapeutics Europe Ltd
Critical Illness
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postpartum Hemorrhage
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Personalized mRNA Tumor Vaccine
The First People's Hospital of Lianyungang
Esophageal Cancer
1 trial -
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Atrium Therapeutics
Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources